David Goldstein
Corporate Officer/Principal en International Society for Pharmacoeconomics & Outcomes Rsch .
Fortuna: 3 M $ al 31/05/2024
Perfil
David M.
Goldstein has worked as a Meetings Manager at the International Society for Pharmacoeconomics & Outcomes Research since 2012.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA. 0.38% | 01/07/2024 | 216 897 ( 0.38% ) | 3 M $ | 31/05/2024 |
Cargos activos de David Goldstein
| Empresas | Cargo | Inicio |
|---|---|---|
International Society for Pharmacoeconomics & Outcomes Rsch
 International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
International Society for Pharmacoeconomics & Outcomes Rsch
International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries. | Commercial Services |
- Bolsa de valores
- Insiders
- David Goldstein
